That is what I hope for, I have not been guided by anybody on this. I base it on the fact that this is just an interim on a small sample size (270 patients).
It could well be 2 weeks, 3weeks a month?
I know that Starpharma announced they finished two of their P3 trials, and advised the full analysis and compilation would take 10-12 weeks. However their trial had a much larger dataset, and it is final - so there will be QC and auditing requiring. Ours is just an interim, with a recommendation given.
- Forums
- ASX - By Stock
- Ann: Process Initiated For CHF P3 Interim Analysis
That is what I hope for, I have not been guided by anybody on...
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
94.5¢ |
Change
-0.025(2.58%) |
Mkt cap ! $1.078B |
Open | High | Low | Value | Volume |
98.0¢ | 98.5¢ | 94.0¢ | $2.482M | 2.602M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 71720 | 94.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
94.5¢ | 10463 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 65720 | 0.940 |
3 | 31070 | 0.935 |
4 | 85753 | 0.930 |
2 | 9000 | 0.925 |
5 | 75776 | 0.920 |
Price($) | Vol. | No. |
---|---|---|
0.945 | 10463 | 1 |
0.950 | 50000 | 2 |
0.955 | 64000 | 1 |
0.960 | 30220 | 3 |
0.965 | 44050 | 3 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |